China Approves World's First Inhaled COVID-19 Vaccine

By Ned Kelly, September 13, 2022

0 0

China has become the first country to approve an inhaled COVID-19 vaccine, reports the BBC.

Named Convidecia Air, it is inhaled as a fine mist, and can provide good protection after just one breath, according to developer CanSino.

Scientists believe nasal spray vaccines may give added immunity in the lining of the nose and upper airways, where COVID-19 typically enters the body.

Convidecia Air contains similar ingredients to CanSino's injected vaccine, using a harmless adenovirus as a carrier for the genetic code that teaches the body how to fight COVID-19.

The National Medical Products Administration of China granted CanSino approval for its inhaled vaccine to be used as a booster dose, topping up protection in those who have previously had a jab.

For all the latest COVID-19 news, follow us on WeChat:


[Cover image via]

more news

Big Name Concerts Back! Overseas Artists Can Return to China

A government announcement regarding procedures getting back to normal is a good sign for the performing arts industry.

China Visas Back To Normal! 5 Things to Know

China had placed restrictions on visas for foreigners since March, 2020 due to COVID-19.

Is It Worth Getting an MBA in China?

There are many benefits of an MBA: networking, leadership, and employability

11 Amazing Trips to Take Around China This Spring

Start the Year of the Rabbit off right.

6 Countries Scrap PCR Test for China Returnees

Rapid antigen testing from here on in.

This Day in History: Ernest Hemingway's 1941 Trip to China

The Old Man and the ROC: When the Dean of American Literature came to China.

8 More Amazing Trips to Take Around China This Spring

Start the Year of the Rabbit off right.

0 User Comments

In Case You Missed It…

We're on WeChat!

Scan our QR Code at right or follow us at ThatsGuangzhou for events, guides, giveaways and much more!

7 Days in Guangzhou With

Weekly updates to your email inbox every Wednesday

Download previous issues

Never miss an issue of That's !

Visit the archives